The effect of sequential therapy for postmenopausal women with osteoporosis: A PRISMA-compliant meta-analysis of randomized controlled trials

BACKGROUND: Osteoporosis, more likely to occur in postmenopausal women, is a chronic condition that usually requires a long-term treatment strategy, but the use of either antiresorptive or anabolic drugs should be limited to 18 to 24 months. Discontinuing antiosteoporosis drugs may result in rapidly...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Shenghan, Lv, Houchen, Wang, Guoqi, Li, Zhirui, Li, Ming, Zhang, Licheng, Tang, Peifu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266008/
https://www.ncbi.nlm.nih.gov/pubmed/27930536
http://dx.doi.org/10.1097/MD.0000000000005496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266008/
https://www.ncbi.nlm.nih.gov/pubmed/27930536
http://dx.doi.org/10.1097/MD.0000000000005496

Ejemplares similares